Chicago, IL, April 15, 2026 (GLOBE NEWSWIRE) -- ONTO Health ("ONTO"), an AI-enabled, physician-led fertility and longevity provider, has announced the close of a $20 million Series A financing round funded by long-time healthcare investors, ARTIS and Humania. The ONTO Health platform combines evidence-based fertility care with AI-driven diagnostics, clinical automation, and longevity science. The new funding will support additional clinical operations in the U.S., as well as expansion into the Gulf Cooperation Council (GCC) region.

ONTO was founded by ARTIS and ONTO's CEO, Roohi Jeelani, MD, FACOG, a double board-certified Reproductive Endocrinology and Infertility specialist recognized for her leadership in fertility care and women's health innovation. ONTO's AI integrates automation, advanced diagnostics, and individualized treatment planning to support clinical decision-making and improve patient outcomes.

Dr. Roohi Jeelani, ONTO Health's CEO and Co-Founder, said: "ONTO was built to meet people where they are and to stay with them as their needs evolve. Fertility care has often been too narrowly focused. We view reproductive care as part of a broader, lifelong health journey rather ...